a sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation

More recent immune thrombocytopenia (itp) treatment strategies enhance platelet production with the use of thrombopoietin receptor agonists (tpo-ra) such as eltrombopag. patients receiving tpo-ra agents be at an increased risk of thromboembolism, however the pathophysiology and common underlying risk factors are not well understood. we present the case of a young asplenic woman on eltrombopag for chronic itp with acute myocardial infarction involving the right coronary artery. past medical history was significant for remote mediastinal radiation for lymphoma and splenectomy for itp. she had no other risk factors for coronary artery disease. she underwent coronary catheterization and balloon angioplasty to the culprit lesion, although stenting was deferred due to concerns with dual antiplatelet therapy. she was discharged from hospital on single antiplatelet therapy with acetylsalicylic acid. we believe that the patient’s itp, recent eltrombopag use, surgical asplenia and history of mediastinal radiation synergistically contributed to her myocardial infarction. the risks of bleeding and thromboembolism must be carefully weighed in patients receiving tpo-ra therapy.